RE: extropian investment: Alteon (long)

From: Rafal Smigrodzki (rafal@smigrodzki.org)
Date: Wed Jun 11 2003 - 16:20:52 MDT

  • Next message: Adrian Tymes: "Re: How best to spend US$200 billion?"

     Ramez Naam wrote:

    The potential market for ALT-711 is multiple billions of dollars per year.

    ### There is a lot of competition between blood pressure drugs, so even if
    the pie is huge, the slices can get thin. This is a source of uncertainty -
    if ALT-711 develops as something more than just a blood pressure drug in the
    minds of physicians and patients, the gain could be as you say, but
    otherwise sales could be disappointing.

    I have Alteon stock and for now I'm holding on to it, especially after
    reading your analysis. BTW, my purchase of Alteon is an example of using
    generally accessible data to gain above-average return - I did believe that
    AGE formation is a very smart hypothesis ever since I read about it in SciAm
    decades ago, and when Robert Bradbury mentioned Alteon, I had more than just
    a hunch that their drug would work. For the same reasons, well-grounded,
    professional optimism regarding the underlying technology, and not technical
    analysis of the stock itself, I put almost all of my cash in AFFX when they
    were still trading at 16$ a share. I didn't have the sense to sell it when
    they traded at 160, so I have to admit that aside from the narrow use of my
    professional knowledge I am a very clumsy trader.

    Rafal



    This archive was generated by hypermail 2.1.5 : Wed Jun 11 2003 - 13:28:39 MDT